Transcend Capital Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
10,153
-249
| -2% | -$30.1K | 0.09% | 191 |
|
|
2025
Q1 | $1.16M | Buy |
10,402
+14
| +0.1% | +$1.56K | 0.08% | 230 |
|
|
2024
Q4 | $1.01M | Sell |
10,388
-45
| -0.4% | -$4.38K | 0.07% | 237 |
|
|
2024
Q3 | $1.2M | Sell |
10,433
-740
| -7% | -$85.1K | 0.08% | 237 |
|
|
2024
Q2 | $1.19M | Sell |
11,173
-47
| -0.4% | -$5K | 0.09% | 227 |
|
|
2024
Q1 | $1.09M | Sell |
11,220
-100
| -0.9% | -$9.67K | 0.09% | 220 |
|
|
2023
Q4 | $1.14M | Sell |
11,320
-192
| -2% | -$19.4K | 0.1% | 202 |
|
|
2023
Q3 | $1.17M | Sell |
11,512
-573
| -5% | -$58.4K | 0.11% | 184 |
|
|
2023
Q2 | $1.22M | Buy |
12,085
+169
| +1% | +$17.1K | 0.12% | 186 |
|
|
2023
Q1 | $1.1M | Sell |
11,916
-466
| -4% | -$42.9K | 0.11% | 186 |
|
|
2022
Q4 | $1.12M | Sell |
12,382
-237
| -2% | -$21.5K | 0.12% | 188 |
|
|
2022
Q3 | $959K | Sell |
12,619
-146
| -1% | -$11.1K | 0.11% | 195 |
|
|
2022
Q2 | $1.08M | Sell |
12,765
-942
| -7% | -$79.6K | 0.11% | 190 |
|
|
2022
Q1 | $1.2M | Buy |
13,707
+409
| +3% | +$35.9K | 0.11% | 196 |
|
|
2021
Q4 | $1.16M | Buy |
13,298
+1,426
| +12% | +$125K | 0.1% | 198 |
|
|
2021
Q3 | $1.01M | Buy |
+11,872
| New | +$1.01M | 0.09% | 212 |
|
|
2021
Q2 | – | Sell |
-12,003
| Closed | -$1.03M | – | 392 |
|
|
2021
Q1 | $1.03M | Sell |
12,003
-394
| -3% | -$33.6K | 0.12% | 177 |
|
|
2020
Q4 | $1.17M | Buy |
12,397
+592
| +5% | +$55.9K | 0.15% | 150 |
|
|
2020
Q3 | $1.03M | Buy |
11,805
+439
| +4% | +$38.2K | 0.19% | 112 |
|
|
2020
Q2 | $993K | Sell |
11,366
-2,789
| -20% | -$244K | 0.32% | 77 |
|
|
2020
Q1 | $1.17M | Sell |
14,155
-518
| -4% | -$42.9K | 0.35% | 81 |
|
|
2019
Q4 | $1.39M | Buy |
+14,673
| New | +$1.39M | 0.37% | 85 |
|